Clostridium difficile Toxin A (toxA or EC 3.4.22.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players
Clostridium difficile Toxin B (toxB or EC 3.4.22.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players
Plasma Kallikrein (Fletcher Factor or Kininogenin or Plasma Prekallikrein or KLKB1 or EC 3.4.21.34) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players
Prolyl Endopeptidase (Post Proline Cleaving Enzyme or PREP or EC 3.4.21.26) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players
Plasminogen (Plasmin or PLG or EC 3.4.21.7) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players